T: +32 (0)474 98 86 68
Biorisk is the application of risk management in areas where the principal hazards is a biological agent. We provide risk management services to biological containment laboratories and other sectors working with potentially harmful biological organisms and their products.
Services & solutions
The main objective of DNV’s biorisk services is to strengthen our biorisk knowledge and networks while also developing biorisk specific methodologies and tools to help our customers effectively manage the biorisks within their organisation. At DNV, we use risk-based approach to identify the hazards and risk associated with biological agents and its products, and also ensure appropriate biorisk controls are identified and implemented in organisations wishing to operate their laboratories in safety and responsibly.
Infection control risk assessment, audit and training
A new strain of influenza virus is spreading around the world causing public health concerns, costly disruption to business and anxiety to individuals and their families. In such a situation, understanding the prevention and control of infection is essential for the well-being and safety of the staff, family and community.
Biorisk training
DNV has designed a series of training courses to provide laboratory managers, biosafety personnel and scientific staff with the required skills and aptitudes necessary to effectively manage biorisk.
Contact
Gerelateerd links
Downloads
Actueel
Biorisk – a global issue
The management of biosafety and biosecurity (collectively know as biorisk) have become a vital global issue, especially in light of the laboratory-acquired cases of SARS in Singapore, Taiwan and China in 2004.
Combating avian flu
Indonesia is now the country with the highest number of human fatalities caused by the H5N1 influenza virus, often referred to as ‘avian flu’. In an effort to tackle the deadly disease, the prestigious Eijkman Institute in Jakarta has built a new biosafety level 3 (BSL3) laboratory – with the help of DNV.
A Star in the making
The Agency for Science, Technology and Research (A*STAR) is leading the way in biomedical research – with the help of DNV.
